San Francisco, CA, United States of America

Philip Ling Kong

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Philip Ling Kong - Pushing Boundaries in Biomedical Innovations

Introduction: Meet Philip Ling Kong, a prolific inventor based in San Francisco, CA, who has made significant contributions to the field of biomedicine through his cutting-edge patent inventions.

Latest Patents: Philip Ling Kong recently patented two groundbreaking inventions. The first, "Anti-MS4A4A antibodies and methods of use thereof," focuses on developing compositions containing antibodies that specifically target the MS4A4A protein, with potential applications in preventive and therapeutic healthcare. The second patent, "Anti-TREM2 antibodies and methods of use thereof," similarly explores antibodies that bind to the TREM2 protein, opening doors for innovative treatment approaches.

Career Highlights: Philip Ling Kong is a key figure at Alector LLC, an influential player in the biotech industry known for its pioneering research and development initiatives. As a dedicated researcher and inventor, Philip has amassed a total of 4 patents, showcasing his expertise and commitment to driving innovation in the medical field.

Collaborations: In his professional journey, Philip Ling Kong has collaborated closely with esteemed colleagues such as Tina Schwabe and Ilaria Tassi. Together, they have shared insights, tackled challenges, and collectively advanced the frontiers of biomedical science.

Conclusion: Philip Ling Kong's inventive spirit and relentless pursuit of excellence exemplify the essence of innovation in the realm of biomedicine. His patents stand as a testament to his vision and dedication to improving healthcare outcomes, solidifying his legacy as a trailblazer in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…